Trial · NCT07897981
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intrahepatic lipid (IHL) | Baseline, up to 60 days of the study | IHL content was assessed by MRI using a 3.0-T scanner |
| Secondary | alanine aminotransferase (ALT, U/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. AST was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | γ-glutamyltransferase (GGT, U/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. GGT was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | aspartate aminotransferase (AST, U/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. AST was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | Hemoglobin A1c (HbA1c, %) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. HbA1c was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | Fasting blood glucose (FBG, mmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. FBG was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | serum triglycerides (TG, mmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. TG was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | total cholesterol (TC, mmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. TC was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | low-density lipoprotein cholesterol (LDL-C, mmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. LDL-C was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Secondary | high-density lipoprotein cholesterol (HDL-C, mmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. HDL-C was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Other | Tumor necrosis factor (TNF-α, pg/mL) | Baseline, up to 60 days of the study | Serum TNF-α was performed using a cytometric bead array (CBA) method with a commercially available human inflammatory cytokine kit (BD Biosciences, Heidelberg, Germany). |
| Other | interleukins (IL-1β, pg/mL) | Baseline, up to 60 days of the study | Serum IL-1β was performed using a cytometric bead array (CBA) method with a commercially available human inflammatory cytokine kit (BD Biosciences, Heidelberg, Germany). |
| Other | Blood creatinine (CREA, μmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. CREA was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Other | urea nitrogen (BUN, mmol/L) | Baseline, up to 60 days of the study | Fasting blood samples were collected at baseline and week 12 after an overnight fast. Serum was separated from blood samples after centrifugation with 3,000 rpm at 4°C for 10 min, and immediately stored at -80°C until use. BUN was measured using an automated biochemical analyzer (HITACHI LABOSPECT 008, Sysmex, Kobe, Japan) |
| Other | Intestinal flora | Baseline, up to 60 days of the study | 16s rRNA sequencing |
| Other | serum untargeted metabolomics | Baseline, up to 60 days of the study | Serum untargeted metabolomics was performed using a Vanquish UHPLC system coupled to an Orbitrap Exploris 120 mass spectrometer (Thermo Fisher Scientific, USA) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07897981/registered